Skip to main content

LidoSite FDA Approval History

Last updated by Judith Stewart, BPharm on Jan 28, 2021.

FDA Approved: Yes (First approved May 10, 2004)
Brand name: LidoSite
Generic name: lidocaine and Epinephrine
Dosage form: Topical System
Company: Vyteris, Inc.
Treatment for: Local Anesthesia

LidoSite (lidocaine and epinephrine) is an iontophoretic delivery system providing local analgesia prior to the administration of superficial dermatological procedures.

Development Timeline for LidoSite

DateArticle
May 10, 2004Approval  LidoSite Vyteris, Inc. - Treatment for Localized Pain

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.